Home
About
Product
News
Honor
Contact
Purchasing
Company News
Industry trends
Purchasing information
2017-12-11
According to the Metropolitan Metro News, a new report shows that the price of a cancer drug has risen by nearly 1400% in just five years. According to the Wall Street Journal, Lomustine is a drug for treating lymphoma and brain tumors. Its current price is $768, compared with $50 in 2013. The price of the drug rose steadily after it was acquired by NextSource Pharmaceutical Company in 2013. Because there was no alternative drug, some cancer patients had to bear huge drug costs, while some patients stopped taking the drug because they could not afford it. NextSource Chief Executive
2017-12-29
Heparin Sodium 2026: Pharmaceutical Grade Manufacturer, Quality Specs & Sourcing Guide
2026-11-13
Aprotinin Raw Material 2026: Uses, Quality Standards & Sourcing Guide
2026-11-08
Aprotinin Manufacturer 2026: Definition, Uses, Quality Specs, Sourcing Guide
2026-11-03
Aprotinin: GMP-Grade Pharmaceutical Raw Material for Global Clinical Supply 2026
2026-10-29
Aprotinin 2026 Raw Material Guide: Trusted Manufacturer & Supplier | RunquanKang
2026-10-24
Exploring the Sweet Side of Anhydrous Sodium Saccharin in Various Industries
2025-12-29